hrp0097p1-416 | Bone, Growth Plate and Mineral Metabolism | ESPE2023

Treatment dilemma in a prepubertal patient with ACAN mutation but without advanced bone age

Hürmüzlü Közler Selen , Gürpınar Gözde , Kilci Fatih , Koçyiğit Esra , Alanay Yasemin , Jones Jeremy , Mine Çizmecioğlu Jones Filiz

Introduction: Aggrecan is a major proteoglycan component of the articular and growth plate extracellular matrix, encoded by the ACAN gene (MIM: 155760). Although short stature and various dysmorphic findings are observed in individuals with ACAN mutations, the relationship between genotype and phenotype is not clear.Case: A 6.75-year-old pre-pubertal girl presented with disproportionate short stature. She was full term f...

hrp0097p1-529 | Growth and Syndromes | ESPE2023

A Rare Cause of Pathological Tall Stature: Luscan Lumish Syndrome

Hürmüzlü Közler Selen , Kilci Fatih , Gürpınar Gözde , Koçyiğit Esra , Jones Jeremy , Mine Çizmecioğlu Jones Filiz

Introduction: Luscan-Lumish syndrome (LLS) is a postnatal overgrowth syndrome characterized by macrocephaly, mental retardation, seizures, postnatal overgrowth, and developmental delay, caused by a heterozygous mutation in the SETD2 gene on chromosome 3p21, which exhibits autosomal dominant inheritance.Case Report: A ten-year-old girl presented with menarche. She was born to healthy non-consanguineous parents at 37 weeks...

hrp0097p2-141 | Adrenals and HPA Axis | ESPE2023

Pediatric Cushing Disease: a single center experience

Koçyiğit Esra , Gürpınar Gözde , Hürmüzlü Gözler Selen , Kilci Fatih , Mİne Çizmecioğlu Jones Filiz , Ceylan Savaş

Introduction: The incidence of Cushing disease (CD) is 0.7-2.4/year per million, andadolescents and children make up 10% of new cases annually. However, thesensitivity and specificity of tests used to diagnose CD in childhood may bepoor, resulting in difficulties in diagnosis and treatment. The aim was to reportpediatric CD patients attending our pituitary referral center for surgery and todescribe their diagnosis, treatment and long-term follow-up.<p clas...

hrp0097p2-240 | Diabetes and Insulin | ESPE2023

Fulminant Type 1 Diabetes Case With Positive Diabetes-Associated Antibodies

Hürmüzlü Közler Selen , Koçyiğit Esra , Sarı Ersöz Hilal , Gürpınar Gözde , Kilci Fatih , Jones Jeremy , Mine Çizmecioğlu Jones Filiz

Introduction: Fulminant type 1 diabetes (FT1D) occurs because of a sudden and almost total destruction of pancreatic β-cells, triggered by a viral infection. FT1DM may cause diabetic ketoacidosis (DKA) and even sudden death. Thus prompt diagnosis is vital.Case Report: Antibiotic treatment was started for a 4-year-old female patient because of a fever and cough. On the second day of treatment, she was admitted with r...

hrp0097p2-150 | Sex Differentiation, Gonads and Gynaecology, and Sex Endocrinology | ESPE2023

46,XY disorders of sex development associated with MAP3K1variants: Case and review of the literature.

Koçyiğit Esra , Hürmüzlü Gözler Selen , Gürpınar Gözde , Kilci Fatih , Mine Çizmecioğlu Jones Filiz

The genetic causes of 46, XY disorders of sex development (DSD) are mostly unknown, having been identified in only 20-35%. Mitogen-activated protein kinase 1, part of the MAPK signaling pathway, which controls testicular development, is one of the etiological genetic pathways. Here, we present a case of 46, XY DSD with heterozygous MAP3K1 variant. A 6-month-old baby was referred to pediatric endocrinology because of ambiguous genitalia. They were born by C-section at 28 weeks ...

hrp0097p1-233 | Diabetes and Insulin | ESPE2023

Diabetes Behind the Mask

Gürpınar Gözde , Koçyiğit Esra , Hürmüzlü Közler Selen , Kilci Fatih , Gür Aykut Gizem , As Yeşilorman Sıdıka , Küçükkeskin , Huw Jones Jeremy , Mine Çizmecioğlu Jones Sema Filiz

Keywords: diabetes, MODY, atypicalIntroduction: Type 1 Diabetes (T1D) is the most common cause of diabetes in childhood, but Type 2 Diabetes (T2D) and monogenic diabetes has attracted increasing attention recently. Cases with atypical diabetes may be challenging for diagnosis, treatment and follow-up management. The purpose of this study was to present the characteristics of atypical diabetes cases from a tertiary referr...

hrp0097p1-471 | Fat, Metabolism and Obesity | ESPE2023

Life-saving management and therapy in a growth-hormone naive superobese adolescent with Prader-Willi Syndrome: Very low energy diet, GLP-1 analog and nasal oxytocin.

Gürpınar Gözde , Kilci Fatih , Koçyiğit Esra , Hürmüzlü Közler Selen , Küçükkeskin Sema , Huw Jones Jeremy , Donaldson Malcolm , Mine Çizmecioğlu Jones Filiz

Introduction: Prader-Willi Syndrome (PWS) is characterized by severe neonatal hypotonia and feeding difficulty with subsequent hyperphagia, hypogonadism, and short stature. PWS has a prevalence of 1 in 10,000-30,000. Obesity-related complications occur from early childhood onwards. Liraglutide is a glucagon-like peptide-1 (GLP-1) analog that reduces appetite and body weight and improves glycemic control. Scarcity of oxytocin-producing neurons in the hypothalam...

hrp0097p1-342 | Pituitary, Neuroendocrinology and Puberty | ESPE2023

The relationship between the amount of ghrelin-positive cells in the stomach and the concentration of ghrelin and anti-ghrelin antibodies in the blood in short stature children, with additional analysis of the impact of H. pylori infection.

Kolasa-Kicińska Marzena , Stawerska Renata , Czkwianianc Elżbieta , Stawerski Wojciech , Stawerski Paweł , Foks Maciej , Lewiński Andrzej

Introduction: The growth process in children depends on GH/IGF-1. Ghrelin is stimulator of GH synthesis. Ghrelin also stimulates the orexigenic center peptides responsible for appetite. It is synthesized in the stomach, thus its secretion may be alter by gastrointestinal tract deseases. Recently, high titers of antibodies against some neuropeptides (including anti-ghrelin) have been found in indyviduals with certain microflora components, e.g. Helicobacter pyl...

hrp0086p1-p110 | Bone &amp; Mineral Metabolism P1 | ESPE2016

Increase in Sclerostin After Rapid Weight Loss in Children

Birkebaek Niels H , Frystyk Jan , Lange Aksel , Holland-Fischer Peter , Kristensen Kurt , Rittig Soren , Vilstrup Henrik , Henning Gronbaek

Background: Sclerostin is secreted by the osteocyte and inhibits bone formation by osteoblasts and is thus a negative regulator of bone formation. In adults, sclerostin levels increase after weight loss, which may be prevented by exercise training. The effect of weight loss on sclerostin in children is unknown.Objective and hypotheses: To compare sclerostin levels in children before and after a 10 weeks stay at a weight loss camp (WLC).<p class="abst...